Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.
EHC 2023
Programm
Personen
Suche
EN
Alle Personen
Peter J. Goadsby
Sortiert nach Typ
Datum
Invited speaker
Plenary lecture
Defining migraine in Stigma: an action plan by EMHA
Plenary lecture
New ideas for trials in cluster headache
Vortrag
ePoster
P177
Efficacy of ubrogepant for the treatment of migraine symptoms during the prodrome (premonitory phase): results from the PRODROME trial
ePoster
P048
Patient responses to atogepant 60 mg once daily: a p
ost hoc
analysis of the ADVANCE trial
ePoster
P107
An economic evaluation of eptinezumab for preventive treatment of migraine in the UK, with consideration for natural history and productivity at work
Abstract lecture
AL009
Ubrogepant for the acute treatment of migraine when administered during the prodrome (premonitory phase): results from a phase 3, randomized, double-blind, placebo-controlled, crossover study
Weitere Beteiligungen
ePoster
P177
Efficacy of ubrogepant for the treatment of migraine symptoms during the prodrome (premonitory phase): results from the PRODROME trial
ePoster
P112
Design of the ContemporAry ProspecTive Understanding of migraine Real-world Evidence (CAPTURE) study
ePoster
LP024
Connective tissue, autonomic and autoimmune differences between vestibular migraine and chronic migraine
ePoster
P048
Patient responses to atogepant 60 mg once daily: a p
ost hoc
analysis of the ADVANCE trial
ePoster
P107
An economic evaluation of eptinezumab for preventive treatment of migraine in the UK, with consideration for natural history and productivity at work
Abstract lecture
AL008
Extended phenotyping of migraine in children: a prospective study in a specialist children's headache clinic
Abstract lecture
AL009
Ubrogepant for the acute treatment of migraine when administered during the prodrome (premonitory phase): results from a phase 3, randomized, double-blind, placebo-controlled, crossover study
ePoster
P230
Observational prospective study on the presence of typical migraine features in nummular headache patients: The Numamig study (NCT04299958)
ePoster
P277
Premonitory symptoms in cluster headache: a comparison between a clinical collection and the broader patient population
ePoster
P209
Altered noradrenergic-enriched connectivity in migraine with and without aura
ePoster
P279
A demographic comparison between the North and South of the UK, in a cluster headache population: What can we learn?
ePoster
P273
Switching preventive migraine treatments during the COVID-19 pandemic: a 4-year observational analysis
Abstract lecture
AL019
PPPD and vestibular migraine: How can we differentiate between these entities?
Abstract lecture
AL021
Medication overuse headache vs. medication overuse, phenotypical differences
© Conventus Congressmanagement & Marketing GmbH
Impressum
Datenschutz